Devic’s Syndrome (Neuromyelitis Optica) Treatment Report

By www.reliablebusinessinsights.com

Report Details

Report Name

Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size, Status And Forecast 2023-2027 Story

Pages

109

Price

$ 3900

Features

Devic’s Syndrome (Neuromyelitis Optica) Treatment Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Alexion Pharmaceuticals, Inc.
Teva Pharmaceuticals
Fresenius Kabi AG
Pharmacia & Upjohn (a subsidary of Pfizer)
Lupin Ltd.
Sagent Pharmaceuticals, Inc.
Zydus Pharmaceuticals, Inc.
Sandoz Inc. (Novartis)
Alkem Laboratories Ltd.
Mylan Pharmaceuticals, Inc.
Hoffmann-La Roche/ Chugai Pharmaceutical
MedImmune LLC
RemeGen, Ltd.